Outcomes of neoadjuvant chemotherapy before CRS-HIPEC for patients with appendiceal cancer.
J C ChenEliza Wright BealJohn HaysTimothy M PawlikSherif Abdel-MisihJordan M CloydPublished in: Journal of surgical oncology (2020)
In this multi-institutional retrospective analysis of patients with peritoneal dissemination from appendiceal cancer, the use of NAC before CRS-HIPEC was associated with worse OS and RFS even after PSM and multivariable regression. Immediate surgery should be considered for patients with disease amenable to complete cytoreduction.
Keyphrases
- neoadjuvant chemotherapy
- papillary thyroid
- low grade
- squamous cell
- locally advanced
- lymph node
- minimally invasive
- sentinel lymph node
- transcription factor
- lymph node metastasis
- coronary artery bypass
- type diabetes
- metabolic syndrome
- radiation therapy
- adipose tissue
- young adults
- rectal cancer
- insulin resistance
- surgical site infection